Camber Capital Management

Latest statistics and disclosures from Camber Capital Management's latest quarterly 13F-HR filing:

Companies in the Camber Capital Management portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Gilead Sciences (GILD) 13.82 +37% 4.00M 70.78
SPDR S&P; 500 ETF (SPY) 11.80 -66% 1000000 241.80
Teva Pharmaceutical Industries (TEVA) 10.16 +20% 6.27M 33.22
Mylan Nv 8.04 +2% 4.25M 38.82
Nektar Therapeutics (NKTR) 5.10 5.35M 19.55
Allergan 4.15 -19% 350000 243.09
Genomic Health (GHDX) 3.91 2.46M 32.55
Brookdale Senior Living (BKD) 3.88 5.40M 14.71
Myriad Genetics (MYGN) 3.78 -30% 3.00M 25.84
Tenet Healthcare Corporation stock 3.78 NEW 4.00M 19.34
Select Medical Holdings Corporation (SEM) 3.75 5.00M 15.35
Bioverativ Inc Com equity 3.45 +6% 1.17M 60.17
Orthofix International Nv Com Stk 3.40 1.50M 46.48
Vertex Pharmaceuticals Incorporated (VRTX) 2.20 -46% 350000 128.87
Sarepta Therapeutics 2.14 -3% 1.30M 33.71
Endo International 1.95 -29% 3.57M 11.17
Endologix (ELGX) 1.78 +25% 7.50M 4.86
AMAG Pharmaceuticals (AMAG) 1.53 NEW 1.70M 18.40
BioScrip (BIOS) 1.35 10.18M 2.72
Biogen Idec (BIIB) 1.32 NEW 100000 271.36
Syneron Medical Ltd ord shs 1.25 2.35M 10.95
Alexion Pharmaceuticals (ALXN) 1.19 NEW 200000 121.67
Axovant Sciences 1.13 NEW 1000000 23.19
Invitae 1.12 2.40M 9.56
Envision Healthcare 1.07 NEW 350000 62.67
Avexis 0.84 NEW 210000 82.16
Rite Aid Corporation (RAD) 0.72 NEW 5.00M 2.95
Ptc Therapeutics I 0.45 -60% 500000 18.33
Atara Biotherapeutics 0.37 +328% 535500 14.00
Arena Pharmaceuticals (ARNA) 0.35 -90% 425000 16.87
Radius Health 0.22 NEW 100000 45.23
Biolase Technology (BLTI) 0.00 7.17M 0.00

Past 13F-HR SEC Filings by Camber Capital Management

View All Filings